Gilead (GILD) Received FDA Orphan Drug Designation for Treatment to Prevent Mother to Child Transmission of Hepatitis B Virus.
Tweet Send to a Friend
Gilead Sciences' (NASDAQ: GILD) tenofovir disoproxil fumarate was granted an Orphan Drug Designation for prevention of mother to child ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
